Invention Application
- Patent Title: Anti-Viral Compounds
- Patent Title (中): 抗病毒化合物
-
Application No.: US14683910Application Date: 2015-04-10
-
Publication No.: US20150218194A1Publication Date: 2015-08-06
- Inventor: Mary E. Bellizzi , David A. Betebenner , Jean C. Califano , Daniel D. Caspi , David A. DeGoey , Pamela L. Donner , Charles A. Flentge , Yi Gao , Charles W. Hutchins , Douglas K. Hutchinson , Tammie K. Jinkerson , Warren M. Kati , Ryan G. Keddy , Allan C. Krueger , Wenke Li , Dachun Liu , Clarence J. Maring , Mark A. Matulenko , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , John K. Pratt , John T. Randolph , Todd W. Rockway , Kathy Sarris , Michael D. Tufano , Seble H. Wagaw , Rolf Wagner , Kevin R. Woller
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Main IPC: C07F9/6558
- IPC: C07F9/6558 ; C07D405/14 ; C07D403/14 ; C07D401/14 ; C07D207/09 ; C07D491/113 ; C07D413/14 ; C07D471/04 ; C07C201/06 ; C07D207/08 ; C07D207/16 ; C07D417/14
Abstract:
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Information query
